Bedrosian Camille L
SEC insider (Form 3/4/5 filer). CIK 0001326969. Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX) and 2 other issuers. 18 reported Form 4/5 transactions since Sep 2024; latest on Sep 10, 2026. Located in SAN DIEGO, CA.
Companies Bedrosian Camille L has filed insider reports for
- Amylyx Pharmaceuticals, Inc. (AMLX): Officer, Chief Medical Officer
- Crinetics Pharmaceuticals, Inc. (CRNX): Director
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Director
Bedrosian Camille L
CIK: 0001326969
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Sep 10, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect7.9K shares at avg. $32.21$256K - Sep 10, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect2.1K shares at avg. $33.09$69K - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect5.9K shares at avg. $85.00$504K - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect16.3K shares at avg. $85.00$1.4M - Aug 18, 2026AMLX
Amylyx Pharmaceuticals, Inc.
AwardDirect22.8K shares- - Jun 18, 2026CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect5.9K shares- - Mar 5, 2026AMLX
Amylyx Pharmaceuticals, Inc.
AwardDirect96K shares- - Mar 2, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect6.5K shares at avg. $14.58$94K - Dec 1, 2025AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect6.6K shares at avg. $14.35$94K - Sep 30, 2025AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect12K shares at avg. $14.58$176K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 10, 2026 |  AMLX Amylyx Pharmaceuticals, Inc. | Sale | 7,947 | $32.21 | $256,004 | Direct |
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 2,081 | $33.09 | $68,864 | Direct |
| Sep 1, 2026 |  CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 5,925 | $85.00 | $503,625 | Direct |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 16,300 | $85.00 | $1,385,500 | Direct |
| Aug 18, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Award | 22,807 | - | $0 | Direct |
| Jun 18, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 5,925 | - | $0 | Direct |
| Mar 5, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Award | 95,990 | - | $0 | Direct |
| Mar 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 6,461 | $14.58 | $94,205 | Direct |
| Dec 1, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 6,580 | $14.35 | $94,418 | Direct |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 12,039 | $14.58 | $175,518 | Direct |
1-10 of 18 transactions